Bristol-Myers Squibb
BMY
#190
Rank
S$137.03 B
Marketcap
S$67.31
Share price
1.94%
Change (1 day)
-11.13%
Change (1 year)

Revenue for Bristol-Myers Squibb (BMY)

Revenue in 2025 (TTM): S$63.18 Billion

According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM ) is S$62.23 Billion. In 2024 the company made a revenue of S$65.65 Billion an increase over the revenue in the year 2023 that were of S$59.43 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bristol-Myers Squibb from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) S$63.18 B-3.76%
2024 S$65.65 B10.45%
2023 S$59.43 B-3.95%
2022 S$61.88 B-1.32%
2021 S$62.70 B11.48%
2020 S$56.24 B59.58%
2019 S$35.24 B14.36%
2018 S$30.82 B10.92%
2017 S$27.78 B-1.17%
2016 S$28.11 B20.03%
2015 S$23.42 B11.64%
2014 S$20.98 B1.07%
2013 S$20.75 B-3.66%
2012 S$21.54 B-21.68%
2011 S$27.51 B9.62%
2010 S$25.09 B7.07%
2009 S$23.44 B-20.42%
2008 S$29.45 B11.96%
2007 S$26.30 B-4.22%
2006 S$27.46 B-14.1%
2005 S$31.97 B11.6%
2004 S$28.65 B-19.77%
2003 S$35.71 B13.61%
2002 S$31.43 B-11.45%
2001 S$35.50 B7.41%
2000 S$33.05 B2.49%
1999 S$32.25 B6.85%
1998 S$30.18 B7.21%
1997 S$28.15 B33.55%
1996 S$21.08 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
S$81.35 B 30.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$83.23 B 33.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$76.99 B 23.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$73.04 B 17.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$61.57 B-1.06%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
S$75.31 B 21.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
S$119.39 B 91.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$77.28 B 24.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$46.60 B-25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$13.04 B-79.04%๐Ÿ‡บ๐Ÿ‡ธ USA